CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Xcorporeal, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Xcorporeal, Inc.
12121 Wilshire Blvd Ste 350
Phone: (310) 923-9990p:310 923-9990 LOS ANGELES, CA  90025-1176  United States Ticker: XCRPXCRP

This company ceased filing statements with the SEC on 3/26/2010.

Business Summary
Xcorporeal, Inc. is a medical device company developing platform technology to be used in devices to replace the function of various human organs. The platforms lead to three initial products: portable artificial kidney (PAK), for attended care renal replacement therapy (RRT), for patients suffering from acute renal failure (ARF); a PAK for home hemodialysis for patients suffering from end stage renal disease (ESRD), and a wearable artificial kidney (WAK) for continuous ambulatory hemodialysis for treatment of ESRD.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/200912/31/2008YesYes---

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer Kelly J.McCrann 58 10/2/2008 10/1/2007
General Partner LesterSideropoulos
Chief Financial Officer, Secretary RobertWeinstein 62 10/1/2007 10/1/2007
4 additional Officers and Directors records available in full report.

Business Names
Business Name
CT Holdings Enterprises, Inc.
CT Holdings Enterprises, Inc.s
Xcorporeal Inc
Xcorporeal Operations, Inc. — Delaware
XCRP

General Information
Number of Employees: 24 (As of 12/31/2008)
Outstanding Shares: 15,154,687 (As of 4/18/2011)
Shareholders: 797
Stock Exchange: OTC
Federal Tax Id: 752242792
Email Address: invest@citadel.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, August 28, 2023